Informatie:
Fout:
ID
11716
Beschrijving
To collect data on safety and effectiveness of dalteparin in the management of non-ST segment elevated acute coronary syndromes in nursing home patients who will be treated conservatively (without percutaneous corornary intervention [PCI] or coronary artery bypass graft [CABG] within 48 hours). https://clinicaltrials.gov/ct2/show/NCT00922766
Link
https://clinicaltrials.gov/ct2/show/NCT00922766
Trefwoorden
Versies (1)
- 28-07-15 28-07-15 -
Geüploaded op
28 juli 2015
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Dalteparin Acute Coronary Syndrome NCT00922766
Eligibility Criteria
- StudyEvent: ODM
Similar models
Eligibility Criteria
- StudyEvent: ODM
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Gender
Item
Male or female patients
boolean
C0079399 (UMLS CUI-1)
Age
Item
18 years or more
boolean
C0001779 (UMLS CUI-1)
Chest pain
Item
Presenting with chest pain
boolean
C0008031 (UMLS CUI-1)
CABG
Item
No coronary bypass graft
boolean
C0010055 (UMLS CUI-1)
PCI
Item
No PCI
boolean
C1532338 (UMLS CUI-1)
Informed consent
Item
Evidence of a personally signed and dated informed consent document
boolean
C0021430 (UMLS CUI-1)
Dalteparin
Item
Recieved Dalteparin
boolean
C0206461 (UMLS CUI-1)
Dalteparin contraindicated
Item
Dalteparin contraindicated
boolean
C0206461 (UMLS CUI-1)
C0522473 (UMLS CUI-2)
C0522473 (UMLS CUI-2)